Interleukin-18: a mediator of inflammation and angiogenesis in rheumatoid arthritis.
about
Endothelial Dysfunction and Inflammation: Immunity in Rheumatoid ArthritisA cytokine-centric view of the pathogenesis and treatment of autoimmune arthritisCombined anti-tumor necrosis factor-α therapy and DMARD therapy in rheumatoid arthritis patients reduces inflammatory gene expression in whole blood compared to DMARD therapy aloneYKL-40-Induced Inhibition of miR-590-3p Promotes Interleukin-18 Expression and Angiogenesis of Endothelial Progenitor Cells.Interleukin-18 produced by bone marrow-derived stromal cells supports T-cell acute leukaemia progressionIncreased expression of IL-18 in the serum and islets of type 1 diabetics.Regulation of development of CD56 bright CD11c + NK-like cells with helper function by IL-18.Cytokines in autoimmunity: role in induction, regulation, and treatment.Activation of NALP1 inflammasomes in rats with adjuvant arthritis; a novel therapeutic target of carboxyamidotriazole in a model of rheumatoid arthritis.The role of interleukin-18 in glioblastoma pathology implies therapeutic potential of two old drugs-disulfiram and ritonavir.A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls.The pathogenic role of angiogenesis in rheumatoid arthritis.T Cell-Associated Cytokines in the Pathogenesis of Sjögren's SyndromeProtective effect of Xuebijing injection against acute lung injury induced by left ventricular ischemia/reperfusion in rabbits.Immunoselected STRO-3+ mesenchymal precursor cells reduce inflammation and improve clinical outcomes in a large animal model of monoarthritisTargeted inhibition of IL-18 attenuates irinotecan-induced intestinal mucositis in mice.Therapeutic targets for rheumatoid arthritis: Progress and promises.The potential role of angiogenic factors in rheumatoid arthritis.Nonclassically Secreted Regulators of Angiogenesis.SDF-1 signaling: a promising target in rheumatic diseases.Association of IL-18 promoter gene polymorphisms with rheumatoid arthritis: a meta-analysis.Inflammation (or synovitis)-driven osteoarthritis: an opportunity for personalizing prognosis and treatment?A review on interleukins: The key manipulators in rheumatoid arthritis.Therapeutic effect of erythroid differentiation regulator 1 (Erdr1) on collagen-induced arthritis in DBA/1J mouse.Elevated serum levels of interleukin-1β and interleukin-33 in patients with systemic sclerosis in Chinese population.Detection of Serum Interleukin-6/10/18 Levels in Sepsis and Its Clinical Significance.Mediators of inflammation-induced bone damage in arthritis and their control by herbal productsOptimized "in vitro" culture conditions for human rheumatoid arthritis synovial fibroblasts.Breviscapine reduces acute lung injury induced by left heart ischemic reperfusion in rats by inhibiting the expression of ICAM-1 and IL-18.A time-course microarray data analysis reveals consistent dysregulated genes and upstream microRNAs in autoantibody-mediated arthritis.IL-18 upregulates the production of key regulators of osteoclastogenesis from fibroblast-like synoviocytes in rheumatoid arthritis.Traditional Chinese medicine formula Bi-Qi capsule alleviates rheumatoid arthritis-induced inflammation, synovial hyperplasia, and cartilage destruction in rats.Interleukin-18 Amplifies Macrophage Polarization and Morphological Alteration, Leading to Excessive Angiogenesis.
P2860
Q26749294-EA0D9BCD-4E5A-4656-8223-22EC70EB239BQ26823326-76A2C3BB-BD3B-44A4-BA3A-5FA91D54C504Q28710288-68B18570-AF9E-4BFE-9906-149C122B48FFQ33754824-A11AB34F-4CB8-44C6-9121-51298D6B212CQ34372296-EADFA6DF-E7E2-4108-ADAA-62F2EEC3281BQ35044541-683653B2-C652-4D6C-A4D9-EA4AA67F3B98Q35077632-3A293EF8-A0C8-4DDA-BE93-25B8ABE46BF3Q35294424-9DD6E0DB-1606-4B81-AAAA-6E45BA2B394BQ35846222-7D71409E-4862-489A-A179-D63F723B2B04Q36121190-FA651F1A-C9E9-44B4-9EEA-3C0296026B96Q36790408-3FB3970D-6A96-4979-9222-B71F91B75703Q36934777-BA142C5E-B994-4993-B32A-A6E4C898CA8FQ36957148-6CBEC6B7-8230-4C67-84A1-A059250FAA8AQ37001476-B7A489F5-A593-459F-AF1E-18A105D62F1AQ37630946-E91B3758-5694-495D-9D50-8F0A630F103AQ37719409-BEBB7381-DE93-42D1-B6F0-16D30AB1BEECQ38179461-E9807D63-53A0-4CFC-9A7C-E589D56F151AQ38182175-7CF3E576-C109-49D2-9105-B0063BD53D49Q38186720-E0792FD3-D700-48A0-A5A3-7D11BE0906CBQ38221918-F342B11D-DD5F-43CE-BE39-BB278A42162FQ38395166-4C8EF9C7-DA4E-4614-9455-10BC42C6C0A7Q38612010-75537568-DBDC-4DE8-94DF-E9DC58B44799Q39029629-9C53712A-93DE-4ABA-92B1-EF591636B69AQ39205496-0C9DA9AB-AFC7-4448-9BAE-F9F8C3B9D877Q39374055-082384C0-E488-474B-B3C8-B7E4391DE1D9Q40481255-BA89EC51-F2B0-40E5-B65C-243C7B90149CQ41922030-F1DF598E-D57A-4769-9050-8BF39B9612D5Q42022447-7A9C94C3-D59F-4A5A-ACF9-6478F378F7FBQ42917832-FA936613-5AE1-498F-A35E-D7FED57273A7Q47100328-541FAFE2-794F-4011-BB86-4175F414E5E2Q47192781-B17D8F1E-2322-4F4A-AADC-1385AC1B9BA0Q55039158-1BB363E6-2566-41ED-AF65-598A957D2F33Q55340253-38A2E3DC-589F-43E0-A67C-2D6AF86C3E1A
P2860
Interleukin-18: a mediator of inflammation and angiogenesis in rheumatoid arthritis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Interleukin-18: a mediator of inflammation and angiogenesis in rheumatoid arthritis.
@en
Interleukin-18: a mediator of inflammation and angiogenesis in rheumatoid arthritis.
@nl
type
label
Interleukin-18: a mediator of inflammation and angiogenesis in rheumatoid arthritis.
@en
Interleukin-18: a mediator of inflammation and angiogenesis in rheumatoid arthritis.
@nl
prefLabel
Interleukin-18: a mediator of inflammation and angiogenesis in rheumatoid arthritis.
@en
Interleukin-18: a mediator of inflammation and angiogenesis in rheumatoid arthritis.
@nl
P356
P1476
Interleukin-18: a mediator of inflammation and angiogenesis in rheumatoid arthritis.
@en
P2093
Alisa E Koch
Michael V Volin
P304
P356
10.1089/JIR.2011.0050
P577
2011-08-24T00:00:00Z